Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Cronos Group stock
Own Cronos Group stock in just a few minutes.
Fact checked
Cronos Group Inc is a drug manufacturers-specialty & generic business based in the US. Cronos Group shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars. Cronos Group employs 631 staff and has a trailing 12-month revenue of around USD$37 million.
How to buy shares in Cronos Group
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Cronos Group. Find the stock by name or ticker symbol: CRON. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cronos Group reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cronos Group, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Cronos Group. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Cronos Group share price
Use our graph to track the performance of CRON stocks over time.Cronos Group shares at a glance
Information last updated 2021-03-03.
| 52-week range | USD$4 - USD$15.83 |
|---|---|
| 50-day moving average | USD$11.4579 |
| 200-day moving average | USD$7.7071 |
| Wall St. target price | N/A |
| PE ratio | 37.0035 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$0.287 |
Buy Cronos Group shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cronos Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Cronos Group under- or over-valued?
Valuing Cronos Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cronos Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cronos Group's P/E ratio
Cronos Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Cronos Group shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Cronos Group financials
| Revenue TTM | USD$37 million |
|---|---|
| Gross profit TTM | USD$-17,864,000 |
| Return on assets TTM | -5.78% |
| Return on equity TTM | 5.82% |
| Profit margin | 270.68% |
| Book value | $4.967 |
| Market capitalisation | USD$3.8 billion |
TTM: trailing 12 months
Shorting Cronos Group shares
There are currently 25.9 million Cronos Group shares held short by investors – that's known as Cronos Group's "short interest". This figure is 0.6% down from 26.1 million last month.
There are a few different ways that this level of interest in shorting Cronos Group shares can be evaluated.
Cronos Group's "short interest ratio" (SIR)
Cronos Group's "short interest ratio" (SIR) is the quantity of Cronos Group shares currently shorted divided by the average quantity of Cronos Group shares traded daily (recently around 9.0 million). Cronos Group's SIR currently stands at 2.87. In other words for every 100,000 Cronos Group shares traded daily on the market, roughly 2870 shares are currently held short.
However Cronos Group's short interest can also be evaluated against the total number of Cronos Group shares, or, against the total number of tradable Cronos Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos Group's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Cronos Group shares in existence, roughly 70 shares are currently held short) or 0.1387% of the tradable shares (for every 100,000 tradable Cronos Group shares, roughly 139 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cronos Group.
Find out more about how you can short Cronos Group stock.
Cronos Group share dividends
We're not expecting Cronos Group to pay a dividend over the next 12 months.
Cronos Group share price volatility
Over the last 12 months, Cronos Group's shares have ranged in value from as little as $4 up to $15.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos Group's is 1.9902. This would suggest that Cronos Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cronos Group overview
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.
Frequently asked questions
More guides on Finder
-
How to buy Achilles Therapeutics plc (ACHL) stock when it goes public
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
-
How to buy SEMrush Holdings Inc (SEMR) stock when it goes public
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
-
How to buy ChargePoint (CRON.US) stock when it goes public
Everything we know about the ChargePoint IPO, plus information on how to buy in.
-
How to buy Kaltura Inc (KLTR) stock when it goes public
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
-
How to buy Rocket Lab (CRON.US) stock when it goes public
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
-
How to buy Soho House (CRON.US) stock when it goes public
Everything we know about the Soho House IPO, plus information on how to buy in.
-
How to buy VIZIO (VZIO) stock when it goes public
Everything we know about the VIZIO IPO, plus information on how to buy in.
-
How to buy IDW Media Holdings Inc (IDW) stock when it goes public
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
-
How to buy Karooooo Ltd (KARO) stock when it goes public
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
-
How to buy Connect Biopharma Holdings Limited (CNTB) stock when it goes public
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
Ask an Expert